The chase ended with a wreck and the suspect assaulting at least one Tupelo police officer.
Police spokesman Capt. Chuck McDougald said members of the Tupelo Police Department Street Crimes Unit attempted to stop a gold Infinity sedan for a traffic infraction on North Gloster around 4:15 p.m. The car fled north on Gloster, then took McCullough Boulevard to get on Highway 45 South. The chase then headed west on Main Street.
The suspect vehicle collided with two uninvolved vehicles at the intersection of West Main and Rankin Boulevard before running off the road.
âThe adult male driver of the vehicle fled on foot but was quickly apprehended by officers,â McDougald said. âThat suspect did assault an officer by striking him in the face as they were attempting to apprehend him.â
Small, Landmark Trial Sees Magic Mushroom Compound Perform as Well as Antidepressants
15 APRIL 2021
In an ongoing search for new ways to tackle depression, researchers have compared psilocybin, the active compound of magic mushrooms, against a well-established antidepressant in a small phase II trial.
Promisingly, the results show that psilocybin was at least as effective as the common antidepressant when used alongside psychological therapy.
It s still very early research. But previous studies have suggested psilocybin doesn t produce nearly as many side effects as antidepressants and its effects are almost immediate.
Trialing the most common type of antidepressants, selective serotonin reuptake inhibitors (SSRIs), on the other hand, can be a nauseating experience for many of us, involving brain zaps, lethargy and emotional turbulence.
Merck, Ridgeback Biotherapeutics Update Covid Drug Development Program
KENILWORTH (NJ) (dpa-AFX) - Merck (MRK) and Ridgeback Biotherapeutics announced that the companies plan to proceed with the phase 3 portion of phase 2/3 study of investigational drug Molnupiravir in outpatients with Covid-19.
This decision has been made following interim analysis of data from the Phase 2 portion of two ongoing Phase 2/3 studies of molnupiravir in outpatients (MOVe-OUT) and hospitalized patients (MOVe-IN) with Covid-19 and from a previously completed Phase 2a dose-ranging study in outpatients.
Also, the companies have decided to not to proceed to phase 3 study in hospitalized patients, as the data from MOVe-IN indicate that molnupiravir is unlikely to show a clinical benefit in hospitalized patients.
Thermaissance builds fabric technology to combat multi-drug resistant organisms
Thermaissance builds fabric technology to combat multi-drug resistant organisms
15 April 2021 | News Using self-disinfecting fabrics, Thermaissance currently manufactures various medical textiles
To provide healthcare workers with maximum protection against various viral, bacterial and fungal infections, Thermaissance, a Mumbai-based nanotechnology startup, continues its innovation journey.
While Thermaissance’s technology has been scientifically proven to inactivate over 99.99 per cent coronavirus in less than an hour, it has also been proven to kill 99.99 per cent of various Multi-Drug Resistant Organisms (MDROs) such as Methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-Resistant Enterococci (VRE), Carbapenem-Resistant Enterobacteriaceae (CRE), and various other bacteria. Thermaissance is one of the very few players in the world to achieve this milestone.
Justin Bieber spoke candidly about the worst part he faced due to his past drug use.
Bieber has been open about his drug use in the past. But this time, he revealed the most serious part he dealt with that almost cost his life.
The 27-year-old Yummy singer recently sat for an interview with GQ Magazine and recalled the time his drug problem was not manageable already.
According to Bieber, his security guards would always look after him at night and check his pulse to determine whether he was still alive. Despite his overwhelming success, the singer turned into drugs in pursuit of feeling satisfied.